Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic? [Yahoo! Finance]
Standard BioTools Inc. (LAB)
Company Research
Source: Yahoo! Finance
Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. On 31 December 2023, the US$1.1b market-cap company posted a loss of US$75m for its most recent financial year. Many investors are wondering about the rate at which Standard BioTools will turn a profit, with the big question being “when will the company breakeven?” In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable. See our latest analysis for Standard BioTools Standard BioTools is bordering on breakeven, according to the 2 American Life Sciences analysts. They expect the company to post a final loss in 2025, before turning a profit of US$9.0m in 2026. The company is therefore projected to breakeven around 2 years from today. What rate will the company have to grow year-on-ye
Show less
Read more
Impact Snapshot
Event Time:
LAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LAB alerts
High impacting Standard BioTools Inc. news events
Weekly update
A roundup of the hottest topics
LAB
News
- Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthGlobeNewswire
- Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024GlobeNewswire
- Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at TD Cowen. They set a "buy" rating and a $3.50 price target on the stock.MarketBeat
LAB
Earnings
- 2/28/24 - Miss
LAB
Sec Filings
- 4/26/24 - Form 10-K/A
- 4/25/24 - Form 8-K
- 4/9/24 - Form 4
- LAB's page on the SEC website